After decades as an unmet medical need, the potential and reality of more efficacious CKD therapeutics is becoming increasingly apparent.
That being said, the leading drug developer organizations are telling us they are frustrated with limited innovation in preclinical models, poor biomarkers to support drug development and a lack of visibility on which contract research organization have the technical experience and credibility to meet their demands.
Over 80 CKD drug developers will come together at CKD3 for the 2nd year, to actively seek partnerships with organization that can help accelerate their CKD candidate development.
So, who will you meet?
CKD3 is a unique platform for you to showcase your solutions, generate new business leads and source opportunities for partnerships for you 2019/2020 business development.
With only limited opportunities available to ensure maximum exposure for those who do partner with CKD3, act now and stay on the radar for the CKD drug development community.
Email email@example.com for more information about the partnership opportunities available which will deliver on your commercial objectives this year.